New naltrexone shot takes on vivitrol in early trial
Disease control
Recruiting now
This early-stage trial tests a new long-acting naltrexone injection (IVL3004) against the approved drug Vivitrol in 40 healthy men. The goal is to compare how the drug moves through the body and check for safety. It does not yet test if it helps treat opioid or alcohol dependence…
Phase: PHASE1 • Sponsor: Inventage Lab., Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:21 UTC